As of August 2026, according to CVS Health's latest financial report, the company's current EPS (TTM) is $3.84. In 2025, the company recorded an earnings per share (EPS) of $1.4, which represents a decrease compared to its EPS of $3.67 in 2024. CVS Health's earnings per share for the quarterly report ending on Jun 30, 2026 was $2.33.
The annual EPS in 2025 was $1.4, a decrease of 61.9% from $3.67 in 2024. For the quarter ending Jun 30, 2026, the EPS was $2.33, showing a 187.7% increase from the same quarter last year. The trailing twelve months (TTM) EPS as of June 2026 is $3.84. In 2024, the annual EPS was $3.67, showing a decrease of 43.5% from 2023.
Over the last 12 months, CVS Health has registered an EPS growth of 187.7% (YoY, quarterly). Over a three-year span, the company had an average EPS growth of -24.8% per year. Over the last 5 years, the company had an average EPS growth rate of -23.9%. When measured over a ten-year period, CVS's average EPS growth rate was -11.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| CVS CVS Health Corp | 25.3 | -61.9% | -24.8% | -23.9% |
| WMT Walmart Inc | 40.45 | 13.2% | 24.2% | 11.5% |
| PETS Petmed Express Inc | N/A | -813.3% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.